Bimzelx (bimekizumab)

pCPA File Number: 22719
Negotiation Status:
Concluded with an LOI
Indication(s):
Psoriatic Arthritis
Sponsor/Manufacturer:
UCB Canada Inc.
CDA-AMC Project Number:
SR0803-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: